Yutaka Hatanaka
- Oncology top 2%
- Pancreatic and Hepatic Oncology Research 14
- HER2/EGFR in Cancer Research 14
- Cancer Cells and Metastasis 12
- Cancer Immunotherapy and Biomarkers 10
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 12
-
- Lung Cancer Treatments and Mutations 15
- Immunology top 10%
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 12
-
- Monoclonal and Polyclonal Antibodies Research 9
- Co-authors
- Yoshihiro MatsunoKanako C. HatanakaYoichi TaniKaoru HashizumeTomoko MitsuhashiKoji TsutaSatoshi HiranoHiroko Yamashita
- Partner nations
- JapanUnited StatesChina
In The Last Decade
Yutaka Hatanaka
134 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 103
- Oncology 1.2k
- Cancer Research 533
- Pulmonary and Respiratory Medicine 653
- Immunology 303
- Pathology and Forensic Medicine 232
Countries citing papers authored by Yutaka Hatanaka
This map shows the geographic impact of Yutaka Hatanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yutaka Hatanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yutaka Hatanaka more than expected).
Fields of papers citing papers by Yutaka Hatanaka
This network shows the impact of papers produced by Yutaka Hatanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yutaka Hatanaka. The network helps show where Yutaka Hatanaka may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yutaka Hatanaka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 4 | |
| 5 | 2023 | 0 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 11 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 2 | |
| 10 | 2022 | 3 | |
| 11 | 2021 | 38 | |
| 12 | 2021 | 16 | |
| 13 | 2020 | 22 | |
| 14 | 2020 | 36 | |
| 15 | 2019 | 24 | |
| 16 | 2017 | 9 | |
| 17 | 2017 | 11 | |
| 18 | 2015 | 13 | |
| 19 | 2010 | 17 | |
| 20 | 2001 | 57 |
About Yutaka Hatanaka
Yutaka Hatanaka is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine, having authored 143 papers that have together received 2.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (15 papers), Pancreatic and Hepatic Oncology Research (14 papers), HER2/EGFR in Cancer Research (14 papers), Cancer Genomics and Diagnostics (12 papers), Cancer Cells and Metastasis (12 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). The work is most often cited by research in Oncology (1.2k citations), Cancer Research (533 citations) and Pulmonary and Respiratory Medicine (653 citations). Yutaka Hatanaka has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Yoshihiro Matsuno, Kanako C. Hatanaka, Yoichi Tani, Kaoru Hashizume, Tomoko Mitsuhashi, Koji Tsuta, Satoshi Hirano, Hiroko Yamashita, Emi Takakuwa and Tadashi Hasegawa. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.